SeroSelectTB: Consortium meeting and start recruitment
The SeroSelectTB Consortium held their first face-to-face meeting in Cape Town from 23-25 August 2022. The meeting included presentations from partners, a workshop addressing data collection, registration and randomisation, and site visits to Wallacedene and Scottsdene health clinics where the study is conducted. Project partners also visited Lateral Flow Laboratories (LFL), the commercial partner responsible for SeroSelectTB test development and production. In addition, meetings were held between LFL and InVivo BioTech and E-MEDDIA to discuss antigen expression and regulatory procedures, respectively.